Frenel Fils DeMorin

Title: Frenel Fils DeMorin: Innovator in Aminopyrimidine Compounds

Introduction

Frenel Fils DeMorin is a notable inventor based in Thousand Oaks, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific diseases. With a total of 5 patents to his name, his work has the potential to impact therapeutic practices significantly.

Latest Patents

Among his latest patents, Frenel has developed aminopyrimidine compounds and methods of use. This invention relates to aminopyrimidine compounds that are useful for treating diseases mediated by polo-like kinase 1 (Plk1). The therapeutic use of these compounds aims to address disease states associated with abnormal cell growth and unwanted cell proliferation. Another significant invention is his work on tricyclic protein kinase inhibitors. This invention provides compounds that are useful as inhibitors of protein tyrosine kinase and serve as antiproliferative agents.

Career Highlights

Frenel has worked with prominent companies in the pharmaceutical industry, including Wyeth and Amgen Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Frenel has collaborated with esteemed colleagues such as Diane H Boschelli and Dan Maarten Berger. These partnerships have fostered an environment of innovation and have led to the advancement of his research.

Conclusion

Frenel Fils DeMorin is a distinguished inventor whose work in aminopyrimidine compounds and protein kinase inhibitors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of various diseases.